Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02977611

The Safety of a High-Dose, Rapid Infusion of Iron Sucrose

The Safety of a High-Dose, Rapid Infusion of Iron Sucrose in a Non-Dialysis Dependent Population

Status
Withdrawn
Phase
Phase 2
Study type
Interventional
Enrollment
0 (actual)
Sponsor
The Guthrie Clinic · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Iron sucrose infusion is an iron replacement used to treat iron deficiency anemia (not enough iron in the body to make hemoglobin). Iron is a mineral that the body needs to produce hemoglobin, which carries oxygen in the blood. When the body does not get enough iron, it cannot produce enough hemoglobin and you become anemic. The research study is looking at the side effects of using a higher dose and faster rate of iron sucrose infusion than what is used in standard of care. The purpose of this study is to see if infusion with 500 mg of iron sucrose over a one hour time period can be done safely. If this can be done safely, it may reduce the total number of infusions required and the time for each infusion. This may be less costly and less burdensome to patients.

Conditions

Interventions

TypeNameDescription
DRUGIron sucroseIron sucrose will be infused at dose of 500 mg over a one hour period

Timeline

Start date
2017-01-01
Primary completion
2017-05-01
Completion
2017-05-01
First posted
2016-11-30
Last updated
2017-10-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02977611. Inclusion in this directory is not an endorsement.